BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29434950)

  • 1. Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.
    Saito M; Goto A; Abe N; Saito K; Maeda D; Ohtake T; Murakami Y; Takenoshita S
    Oncol Lett; 2018 Feb; 15(2):2401-2406. PubMed ID: 29434950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy.
    Kanke Y; Saito M; Abe N; Saito K; Goto A; Ohtake T; Murakami Y; Kono K
    Oncol Lett; 2019 Jan; 17(1):921-926. PubMed ID: 30655848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Contribution of Cadm1-Cadm3 Cell Adhesion Molecules to Peripheral Myelinated Axons.
    Sukhanov N; Vainshtein A; Eshed-Eisenbach Y; Peles E
    J Neurosci; 2021 Feb; 41(7):1393-1400. PubMed ID: 33397712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma.
    Nagata M; Sakurai-Yageta M; Yamada D; Goto A; Ito A; Fukuhara H; Kume H; Morikawa T; Fukayama M; Homma Y; Murakami Y
    Int J Cancer; 2012 Mar; 130(6):1329-37. PubMed ID: 21544807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic adhesion molecules in Cadm family at the neuromuscular junction.
    Tanabe Y; Fujita E; Hayashi YK; Zhu X; Lubbert H; Mezaki Y; Senoo H; Momoi T
    Cell Biol Int; 2013 Jul; 37(7):731-6. PubMed ID: 23505055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Significance of Cell Adhesion Molecule 4 Expression in Gallbladder Cancer and Its Prognostic Role.
    Bang S; Jee S; Son H; Cha H; Song K; Park H; Myung J; Kim H; Paik S
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Expression of Cell Adhesion Molecule 4 in Gastric Adenocarcinoma and Its Prognostic Implications.
    Bang S; Jee S; Son H; Cha H; Sim J; Kim Y; Park H; Myung J; Shin SJ; Kim H; Paik S
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of Interaction Between CADM1 and Its Binding Cell-Surface Proteins Using Surface Plasmon Resonance Imaging.
    Ito T; Kasai Y; Kumagai Y; Suzuki D; Ochiai-Noguchi M; Irikura D; Miyake S; Murakami Y
    Front Cell Dev Biol; 2018; 6():86. PubMed ID: 30131958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.
    Jang SM; Sim J; Han H; Ahn HI; Kim H; Yi K; Jun YJ; Rehman A; Chung MS; Jang K; Paik SS
    J Clin Pathol; 2013 Aug; 66(8):681-6. PubMed ID: 23559354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-homophilic interaction of CADM1 promotes organ infiltration of T-cell lymphoma by adhesion to vascular endothelium.
    Kasai Y; Gan SP; Funaki T; Ohashi-Kumagai Y; Tominaga M; Shiu SJ; Suzuki D; Matsubara D; Sakamoto T; Sakurai-Yageta M; Ito T; Murakami Y
    Cancer Sci; 2022 May; 113(5):1669-1678. PubMed ID: 35213073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of CADM4 expression, and its correlation with expression of E-cadherin and Ki-67 in colorectal adenocarcinomas.
    Jang SM; Han H; Jun YJ; Jang SH; Min KW; Sim J; Ahn HI; Lee KH; Jang KS; Paik SS
    J Clin Pathol; 2012 Oct; 65(10):902-6. PubMed ID: 22718847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
    Takahashi Y; Iwai M; Kawai T; Arakawa A; Ito T; Sakurai-Yageta M; Ito A; Goto A; Saito M; Kasumi F; Murakami Y
    Breast Cancer; 2012 Jul; 19(3):242-52. PubMed ID: 21526423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
    Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
    Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.
    Chen Y; Liu L; Guo Z; Wang Y; Yang Y; Liu X
    Oncol Lett; 2019 Feb; 17(2):2047-2056. PubMed ID: 30719104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas.
    Kim KJ; Kim JY; Hong SM; Gu MJ
    APMIS; 2017 May; 125(5):437-443. PubMed ID: 28444978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
    Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
    Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression.
    Mou K; Zhang X; Mu X; Ge R; Han D; Zhou Y; Wang L
    Front Oncol; 2019; 9():569. PubMed ID: 31334110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Adhesion Molecule 1 (CADM1) Is an Independent Prognostic Factor in Patients with Cutaneous Squamous Cell Carcinoma.
    Saito-Sasaki N; Sawada Y; Okada E; Nakamura M
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34064472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions.
    Koma Y; Furuno T; Hagiyama M; Hamaguchi K; Nakanishi M; Masuda M; Hirota S; Yokozaki H; Ito A
    Gastroenterology; 2008 May; 134(5):1544-54. PubMed ID: 18471525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma.
    Wang F; Qi X; Li Z; Jin S; Xie Y; Zhong H
    Cancer Manag Res; 2019; 11():3813-3828. PubMed ID: 31118799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.